Cyclacel Pharmaceuticals Inc (CYCC)
1.60
-0.70
(-30.43%)
USD |
NASDAQ |
Apr 25, 16:00
1.51
-0.09
(-5.62%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Shareholders Equity (Quarterly): 0.607M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.607M |
| September 30, 2023 | 4.297M |
| June 30, 2023 | 9.63M |
| March 31, 2023 | 14.64M |
| December 31, 2022 | 20.43M |
| September 30, 2022 | 26.56M |
| June 30, 2022 | 30.21M |
| March 31, 2022 | 33.41M |
| December 31, 2021 | 37.69M |
| September 30, 2021 | 41.36M |
| June 30, 2021 | 43.22M |
| March 31, 2021 | 48.05M |
| December 31, 2020 | 33.26M |
| September 30, 2020 | 24.44M |
| June 30, 2020 | 26.58M |
| March 31, 2020 | 10.39M |
| December 31, 2019 | 11.70M |
| September 30, 2019 | 13.85M |
| June 30, 2019 | 15.73M |
| March 31, 2019 | 17.56M |
| December 31, 2018 | 15.27M |
| September 30, 2018 | 16.60M |
| June 30, 2018 | 18.62M |
| March 31, 2018 | 20.40M |
| December 31, 2017 | 21.77M |
| Date | Value |
|---|---|
| September 30, 2017 | 23.46M |
| June 30, 2017 | 11.64M |
| March 31, 2017 | 12.82M |
| December 31, 2016 | 14.27M |
| September 30, 2016 | 16.94M |
| June 30, 2016 | 13.16M |
| March 31, 2016 | 15.90M |
| December 31, 2015 | 18.84M |
| September 30, 2015 | 21.60M |
| June 30, 2015 | 24.10M |
| March 31, 2015 | 27.03M |
| December 31, 2014 | 21.69M |
| September 30, 2014 | 24.64M |
| June 30, 2014 | 29.59M |
| March 31, 2014 | 24.98M |
| December 31, 2013 | 28.02M |
| September 30, 2013 | 29.01M |
| June 30, 2013 | 30.93M |
| March 31, 2013 | 10.23M |
| December 31, 2012 | 10.02M |
| September 30, 2012 | 13.23M |
| June 30, 2012 | 15.06M |
| March 31, 2012 | 18.54M |
| December 31, 2011 | 19.50M |
| September 30, 2011 | 23.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.607M
Minimum
Dec 2023
48.05M
Maximum
Mar 2021
23.48M
Average
24.44M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
| Corvus Pharmaceuticals Inc | 38.68M |
| Oragenics Inc | 3.168M |
| Relmada Therapeutics Inc | 85.36M |
| Alpine Immune Sciences Inc | 327.94M |
| MAIA Biotechnology Inc | 0.4775M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.805M |
| Total Liabilities (Quarterly) | 8.198M |
| Current Ratio | 0.9121 |